Document is current
Any future updates will be listed below
-
Authors
Salmoral, Asunción https://orcid.org/0009-0004-8097-7846
Peris, P.
López Medina, C.
Flórez, H.
Barceló, M.
Pascual Pastor, M.
Ros, I.
Grados, D.
Aguado, P.
García, S.
López, L.
Gifre, L.
Cerdá, D.
Aguilar, F. J.
Panero, B.
Costa, E.
Casado, E.
Hernández, B.
Martínez Ferrer, A.
Graña, J.
Gómez, I.
Guañabens, N.
,
-
Funding
Funding for this research was provided by:
Salmoral A.
- License Information
-
More Information
Article History
Received: 7 July 2024
Accepted: 2 November 2024
First Online: 3 December 2024
Declarations
:
: A. Salmoral has received fees for lectures, courses or congress registration from Theramex, Gedeon-Ritcher and Amgen. P. Peris has received fees for lectures, consultant or congress registration from Amgen, UCB, FAES Pharma, Gedeon Richter Theramex y Rubió. C. López Medina has received honoraria as speaker fees/consulting from Abbvie, Janssen, Lilly, MSD, Novartis, Pfizer and UCB. I. Ros has received fees for lectures or courses from Amgen, UCB and Theramex. P. Aguado has received fees for lectures and/or advice from Abbie, Alexion, Amgen, Astra Zeneca, Eli Lilly, Faes, Gedeon-Richter, GP Pharm, Kyowa Kirin, MSD, Rubió and Theramex. S. Garcia has received fees for lectures or congress registration from Amgen, UCB, Gedeon Richter, Lilly, Abbvie, Grünenthal pharma, Italfarmaco and GP-pharm. L. Gifre declares receipt of lecture fees or congress registration from UCB, Amgen, Rubió, Stada, Theramex, Lilly, Abbie, Astellas, Kyowa Kyrin and Gebro. D. Cerdá has received fees for lectures, consultant or congress registration from Amgen, UCB, Lilly, Gebro, Italfármaco and Abbvie. F. J. Aguilar has received fees for lectures, consultant, editor and congress registration from Amgen, UCB, FAES Pharma, Gebro, Gedeon Richter, Theramex and Asacpharma. E. Costa has received congress funding from Rubió, Amgen and Kyowa-kirin. E. Casado has received fees for conferences and consultancies from Amgen, UCB, Theramex, STADA, Italfarmaco, FAES, Gedeon-Richter, GP-Pharm and Rubió; and has received congress funding from UCB, Amgen, Rubió and Theramex. A. Martínez-Ferrer has received fees for lectures or congress registration from Amgen, UCB, Gedeon Richter, Theramex and STADA. J. Graña has received fees for lectures, consultant or congress registration from Amgen, UCB, FAES Pharma, Gebro, Gedeon Richter and Theramex. N. Guañabens has received honoraria for advisory boards or lectures from Amgen, Eli Lilly, Theramex, Gedeon Richter and UCB.
